Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Int J Mol Sci. 2021 Feb 28;22(5):2421. doi: 10.3390/ijms22052421.
Reactive oxygen species (ROS) plays a key role in the pathogenesis of primary open-angle glaucoma (POAG), a chronic neurodegenerative disease that damages the trabecular meshwork (TM) cells, inducing apoptosis of the retinal ganglion cells (RGC), deteriorating the optic nerve head, and leading to blindness. Aqueous humor (AH) outflow resistance and intraocular pressure (IOP) elevation contribute to disease progression. Nevertheless, despite the existence of pharmacological and surgical treatments, there is room for the development of additional treatment approaches. The following review is aimed at investigating the role of different microRNAs (miRNAs) in the expression of genes and proteins involved in the regulation of inflammatory and degenerative processes, focusing on the delicate balance of synthesis and deposition of extracellular matrix (ECM) regulated by chronic oxidative stress in POAG related tissues. The neutralizing activity of a couple of miRNAs was described, suggesting effective downregulation of pro-inflammatory and pro-fibrotic signaling pathways, including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), transforming growth factor-beta 2 (TGF-β2), Wnt/β-Catenin, and PI3K/AKT. In addition, with regards to the elevated IOP in many POAG patients due to increased outflow resistance, Collagen type I degradation was stimulated by some miRNAs and prevented ECM deposition in TM cells. Mitochondrial dysfunction as a consequence of oxidative stress was suppressed following exposure to different miRNAs. In contrast, increased oxidative damage by inhibiting the mTOR signaling pathway was described as part of the action of selected miRNAs. Summarizing, specific miRNAs may be promising therapeutic targets for lowering or preventing oxidative stress injury in POAG patients.
活性氧 (ROS) 在原发性开角型青光眼 (POAG) 的发病机制中起着关键作用,POAG 是一种慢性神经退行性疾病,可损害小梁网 (TM) 细胞,诱导视网膜神经节细胞 (RGC) 凋亡,使视神经头恶化,并导致失明。房水 (AH) 流出阻力和眼内压 (IOP) 升高会导致疾病进展。尽管存在药理学和手术治疗,但仍有开发其他治疗方法的空间。以下综述旨在研究不同 microRNAs (miRNAs) 在参与调节炎症和退行性过程的基因和蛋白质表达中的作用,重点研究慢性氧化应激在 POAG 相关组织中调节细胞外基质 (ECM) 的合成和沉积的微妙平衡。描述了几种 miRNAs 的中和活性,表明有效下调了促炎和促纤维化信号通路,包括核因子 kappa-轻链增强子的激活 B 细胞 (NF-kB)、转化生长因子-β2 (TGF-β2)、Wnt/β-Catenin 和 PI3K/AKT。此外,对于许多 POAG 患者由于流出阻力增加而导致的 IOP 升高,一些 miRNAs 刺激了 I 型胶原的降解,并防止了 TM 细胞中 ECM 的沉积。暴露于不同的 miRNAs 后,氧化应激导致的线粒体功能障碍得到抑制。相比之下,通过抑制 mTOR 信号通路来增加氧化损伤被描述为选定 miRNAs 作用的一部分。总之,特定的 miRNAs 可能是降低或预防 POAG 患者氧化应激损伤的有前途的治疗靶点。